These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2503412)

  • 1. Contractile properties of cardiac papillary muscle in streptozotocin-diabetic rats and the effects of aldose reductase inhibition.
    Cameron NE; Cotter MA; Robertson S
    Diabetologia; 1989 Jun; 32(6):365-70. PubMed ID: 2503412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats.
    Cameron NE; Cotter MA; Robertson S
    Q J Exp Physiol; 1989 Nov; 74(6):917-26. PubMed ID: 2512591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats.
    Yagihashi S; Kamijo M; Ido Y; Mirrlees DJ
    Diabetes; 1990 Jun; 39(6):690-6. PubMed ID: 2140802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ponalrestat on depressor responses to arachidonic acid in streptozotocin-diabetic rats.
    Law SC; King RG
    Gen Pharmacol; 1990; 21(1):135-9. PubMed ID: 2105258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural observations on myelinated fibres in experimental diabetes: effect of the aldose reductase inhibitor ponalrestat given alone or in conjunction with insulin therapy.
    Bhoyrul S; Sharma AK; Stribling D; Mirrlees DD; Peterson RG; Farber MO; Thomas PK
    J Neurol Sci; 1988 Jun; 85(2):131-47. PubMed ID: 2968441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of aldose reductase inhibition on erythrocyte polyols and galactitol accumulation in diabetic patients.
    Airey CM; Price DE; Kemp JV; Perkins CM; Wales JK
    Diabet Med; 1989 Dec; 6(9):804-8. PubMed ID: 2533041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in skeletal muscle contractile properties in streptozocin-induced diabetic rats and role of polyol pathway and hypoinsulinemia.
    Cameron NE; Cotter MA; Robertson S
    Diabetes; 1990 Apr; 39(4):460-5. PubMed ID: 2108070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat.
    Stribling D; Mirrlees DJ; Harrison HE; Earl DC
    Metabolism; 1985 Apr; 34(4):336-44. PubMed ID: 3920474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of aldose reductase inhibition with ponalrestat on changes in vascular function in streptozotocin diabetic rats.
    Otter DJ; Chess-Williams R
    Br J Pharmacol; 1994 Oct; 113(2):576-80. PubMed ID: 7834210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'.
    Willars GB; Calcutt NA; Tomlinson DR
    Diabetologia; 1987 Apr; 30(4):239-43. PubMed ID: 2439402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ponalrestat: a potent and specific inhibitor of aldose reductase.
    Ward WH; Sennitt CM; Ross H; Dingle A; Timms D; Mirrlees DJ; Tuffin DP
    Biochem Pharmacol; 1990 Jan; 39(2):337-46. PubMed ID: 2105733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'.
    Robinson JP; Willars GB; Tomlinson DR; Keen P
    Brain Res; 1987 Nov; 426(2):339-48. PubMed ID: 2446712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorbitol metabolism in the retina, optic nerve, and sural nerve of diabetic rats treated with an aldose reductase inhibitor.
    Naeser P; Brolin SE; Eriksson UJ
    Metabolism; 1988 Dec; 37(12):1143-5. PubMed ID: 3143049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes-induced changes in cardiac beta-adrenoceptor responsiveness: effects of aldose reductase inhibition with ponalrestat.
    Austin CE; Chess-Williams R
    Br J Pharmacol; 1991 Feb; 102(2):478-82. PubMed ID: 1849772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat.
    Dahlin LB; Archer DR; McLean WG
    Diabetologia; 1987 Jun; 30(6):414-8. PubMed ID: 2445613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on peripheral nerve and lens in long-term experimental diabetes: effects of the aldose reductase inhibitor statil.
    Willars GB; Townsend J; Tomlinson DR; Compton AM; Churchill RD
    Metabolism; 1988 May; 37(5):442-9. PubMed ID: 2452959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired nerve regeneration in streptozotocin-diabetic rats. Effects of treatment with an aldose reductase inhibitor.
    Ekström AR; Tomlinson DR
    J Neurol Sci; 1989 Nov; 93(2-3):231-7. PubMed ID: 2531788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin-induced diabetes: effect of treatment with the aldose reductase inhibitor, ponalrestat.
    Taylor PD; Wickenden AD; Mirrlees DJ; Poston L
    Br J Pharmacol; 1994 Jan; 111(1):42-8. PubMed ID: 8012723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast anterograde axonal transport in wasted and non-wasted diabetic rats; effects of aldose reductase inhibition.
    Whiteley SJ; Townsend J; Tomlinson DR; Willars GB
    Diabetes Res; 1986 Nov; 3(9):447-52. PubMed ID: 2435444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat.
    Sima AA; Prashar A; Zhang WX; Chakrabarti S; Greene DA
    J Clin Invest; 1990 May; 85(5):1410-20. PubMed ID: 2110189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.